![Paul Chaplin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Chaplin
President på
Bavarian Nordic, Inc.
Profil
Paul Chaplin currently works at Bavarian Nordic A, as President & Chief Executive Officer from 2014, Bavarian Nordic, Inc., as President, and Bavarian Nordic GmbH, as General Manager from 1999.
Dr. Chaplin received his doctorate degree from the University of Bristol.
Senaste nyheterna om Paul Chaplin
Aktiva positioner av Paul Chaplin
| Företag | Position | Start |
|---|---|---|
Bavarian Nordic GmbH
 Bavarian Nordic GmbH BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer and infectious diseases | Företagsledare/Principal | 2011-03-03 |
Bavarian Nordic, Inc.
 Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and manufactures drugs to treat cancer | President | - |
Tidigare kända positioner av Paul Chaplin
| Företag | Position | Slut |
|---|---|---|
| BAVARIAN NORDIC A/S | Verkställande Direktör | 2026-10-15 |
Paul Chaplins utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
49
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Bavarian Nordic, Inc.
Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and manufactures drugs to treat cancer | Commercial Services |
Bavarian Nordic A/S
 Bavarian Nordic A/S BiotechnologyHealth Technology Engages in research, development and manufacturing travel vaccines | Health Technology |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bavarian Nordic GmbH
Bavarian Nordic GmbH BiotechnologyHealth Technology Engages in research and development in biotechnology for cancer and infectious diseases | Health Technology |
